374 related articles for article (PubMed ID: 33984603)
21. Reliable Long-Term Serial Evaluation of Cochlear Function Using Pulsed Distortion-Product Otoacoustic Emissions: Analyzing Levels and Pressure Time Courses.
Bader K; Dalhoff E; Dierkes L; Braun LH; Gummer AW; Zelle D
Ear Hear; 2024 May; ():. PubMed ID: 38809242
[TBL] [Abstract][Full Text] [Related]
22. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance.
Norton SJ; Gorga MP; Widen JE; Folsom RC; Sininger Y; Cone-Wesson B; Vohr BR; Mascher K; Fletcher K
Ear Hear; 2000 Oct; 21(5):508-28. PubMed ID: 11059707
[TBL] [Abstract][Full Text] [Related]
23. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
Johnson TA; Baranowski LG
Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
[TBL] [Abstract][Full Text] [Related]
24. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
[TBL] [Abstract][Full Text] [Related]
25. Test-retest repeatability of distortion product otoacoustic emissions.
Wagner W; Heppelmann G; Vonthein R; Zenner HP
Ear Hear; 2008 Jun; 29(3):378-91. PubMed ID: 18382378
[TBL] [Abstract][Full Text] [Related]
26. Effect of calibration method on distortion-product otoacoustic emission measurements at and around 4 kHz.
Reuven ML; Neely ST; Kopun JG; Rasetshwane DM; Allen JB; Tan H; Gorga MP
Ear Hear; 2013; 34(6):779-88. PubMed ID: 24165303
[TBL] [Abstract][Full Text] [Related]
27. Distortion-product otoacoustic emission test performance for ototoxicity monitoring.
Reavis KM; McMillan G; Austin D; Gallun F; Fausti SA; Gordon JS; Helt WJ; Konrad-Martin D
Ear Hear; 2011 Feb; 32(1):61-74. PubMed ID: 20625302
[TBL] [Abstract][Full Text] [Related]
28. Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards.
Gorga MP; Neely ST; Dorn PA
Ear Hear; 1999 Aug; 20(4):345-62. PubMed ID: 10466570
[TBL] [Abstract][Full Text] [Related]
29. Weakened Cochlear Nonlinearity During Human Aging and Perceptual Correlates.
Abdala C; Ortmann AJ; Guardia YC
Ear Hear; 2021; 42(4):832-845. PubMed ID: 33886169
[TBL] [Abstract][Full Text] [Related]
30. The effects of aging on distortion-product otoacoustic emissions in adults with normal hearing.
Uchida Y; Ando F; Shimokata H; Sugiura S; Ueda H; Nakashima T
Ear Hear; 2008 Apr; 29(2):176-84. PubMed ID: 18595184
[TBL] [Abstract][Full Text] [Related]
31. Low-frequency and high-frequency cochlear nonlinearity in humans.
Gorga MP; Neely ST; Dierking DM; Kopun J; Jolkowski K; Groenenboom K; Tan H; Stiegemann B
J Acoust Soc Am; 2007 Sep; 122(3):1671. PubMed ID: 17927427
[TBL] [Abstract][Full Text] [Related]
32. High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions.
Arnold DJ; Lonsbury-Martin BL; Martin GK
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):215-22. PubMed ID: 10037289
[TBL] [Abstract][Full Text] [Related]
33. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity of distortion-product otoacoustic emissions in humans to tonal over-exposure: time course of recovery and effects of lowering L2.
Sutton LA; Lonsbury-Martin BL; Martin GK; Whitehead ML
Hear Res; 1994 May; 75(1-2):161-74. PubMed ID: 8071143
[TBL] [Abstract][Full Text] [Related]
35. Cochlear compression estimates from measurements of distortion-product otoacoustic emissions.
Neely ST; Gorga MP; Dorn PA
J Acoust Soc Am; 2003 Sep; 114(3):1499-507. PubMed ID: 14514203
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
Mills DM; Feeney MP; Gates GA
Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
[TBL] [Abstract][Full Text] [Related]
37. Objective audiometry with DPOAEs : New findings for generation mechanisms and clinical applications.
Zelle D; Dalhoff E; Gummer AW
HNO; 2017 Aug; 65(Suppl 2):122-129. PubMed ID: 28470484
[TBL] [Abstract][Full Text] [Related]
38. Fine alterations of distortion-product otoacoustic emissions after moderate acoustic overexposure in guinea pigs.
Kossowski M; Mom T; Guitton M; Poncet JL; Bonfils P; Avan P
Audiology; 2001; 40(3):113-22. PubMed ID: 11465293
[TBL] [Abstract][Full Text] [Related]
39. ABR and DPOAE detection of cochlear damage by gentamicin.
Shi Y; Martin WH
J Basic Clin Physiol Pharmacol; 1997; 8(3):141-55. PubMed ID: 9429983
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
